Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line

Journal of the National Cancer Institute

Volumn 88, Issue 18, 1996, Pages 1269-1275

  Hochhauser, Daniel ^a   Schnieders, Barbara ^a   Ercikan Abali, Emine ^a   Gorlick, Richard ^a   Muise Helmericks, Robin ^a   Li, Wei Wei ^a   Fan, Jianguo ^a   Banerjee, Debabrata ^a   Bertino, Joseph R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLINE; CYTARABINE; DOXORUBICIN; METHOTREXATE; PACLITAXEL;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DNA TRANSFECTION; DRUG SENSITIVITY; FIBROSARCOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

EID: 0029778442     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.18.1269     Document Type: Article

References (35)

1. Bertino JR, Karnofsky Memorial Lecture. Ode to methotrexate. J Clin Oncol 1993;11:5-14.
2. Hochhauser D, Harris AL. The role of topoisomerase IIα and β in drug resistance. Cancer Treat Rev 1993;19:181-94.
3. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-67.
4. Lowe SW, Bodis S, McClatchley A, Remington L, Ruley HE, Fisher DE, et al. p53 status and the efficacy of cancer therapy in vivo. Science 1994; 266:807-10.
5. Li W, Fan J, Hochhauser D, Banerjee D, Zielinski Z, Almasan A, et al. Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines. Proc Natl Acad Sci U S A 1995;92:10436-40.
6. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.Cell 1992;70:993-1006.
7. Hunter T, Pines J. Cyclins and cancer. II: cyclin D and CDK inhibitors come of age [see comment citation in Medline]. Cell 1994;79:573-82.
8. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci U S A 1994; 91:709-13.
9. Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 1994;13:2124-30.
10. Bartokova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 1994;57:353-61.
11. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B, Bartek J. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res 1995;55:949-56.
12. Rosenberg CL, Wong E, Petty EM, Bale AE, Tsujimoto Y, Harris NL, et al. PRAD1, a candidate BCL 1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci U S A 1991;88:9638-42.
13. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of fortyseven operable squamous cell carcinomas of the head and neck. Cancer Res 1995;55:975-8.
14. Schulze A, Zerfass K, Spitkovsky D, Henglein B, Jansen-Durr P. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1. Oncogene 1994;9:3475-82.
15. Goker E, Waltham M, Kheradpour A, Trippett T, Mazumdar M, Elisseyeff Y, et al. Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations. Blood 1995;86:677-84.
16. Laborda J, 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res 1991;19:3998.
17. Daksis JI, Lu RY, Facchini LM, Marhin WW, Penn LJ. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle, Oncogene 1994; 9:3635-45.
18. Moscow JA, Gong M, He R, Sgagias MK, Dixon KH, Anzick SL, et al. Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells. Cancer Res 1995;55:3790-4.
19. Feinberg AP, Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132:6-13.
20. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, et al. Current protocols in molecular biology. New York: John Wiley & Sons, 1994.
21. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
22. Harlow E, Lane D. Antibodies, a laboratory manual. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory, 1988.
23. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990;82:1107-12.
24. Resnitzsky D, Gossen M, Bujard H, Reed SI. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 1994;14:1669-79.
25. Almasan A, Yin Y, Kelly RE, Lee EY, Bradley A, Li WW. Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci U S A 1995; 92:5436-40.
26. Bates S, Parry D, Bonetta L, Vousden K, Dickson C, Peters G. Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene 1994;9:1633-40.
27. Lukas J, Muller H, Bartkova J, Spitkovsky D, Kjerulff AA, Jansen-Durr P, et al. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement of cyclin D1 function in G1. J Cell Biol 1994;125:625-38.
28. Shao Z, Robbins PD. Differential regulation of E2F and Sp1-mediated transcription by G1 cyclins. Oncogene 1995;10:221-8.
29. Quelle DE, Ashmun RA, Shurtleff SA, Kato J, Bar-Sagi D, Roussel MF. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 1993;7:1559-71.
30. Rao SS, Kohtz DS. Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor beta. A role for cyclin D1 in control of myoblast differentiation. J Biol Chem 1995;270:4093-100.
31. Atadja P, Wong H, Veillete C, Riabowol K. Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts. Exp Cell Res 1995;217: 205-16.
32. Han EK, Sgambato A, Jiang W, Zhang YJ, Santella RM, Doki Y, et al. Stable Overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene 1995;10:953-61.
33. Wilhide CC, Van Dang C, Dipersio J, Kenedy AA, Bray PF. Overexpression of cyclin D1 in the Dami megakaryocytic cell line causes growth arrest. Blood 1995;86:294-304.
34. Zhou P, Jiang W, Zhang YJ, Kahn SM, Schieren I, Santella RM, et al. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene 1995;11:571-80.
35. Cordon-Cardo C. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol 1995;147:545-60.